Trogarzo 200 MG/1.33 ML vial 1.33ML
Ended Awarded
- Contract number
- SPE2DB25FPRB1
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $46,650
Award facts
- Contract value 100% obligated
- $46,649.70 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $46,649.70 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Trogarzo 200 mg/1.33 ml vials. The contract is firm fixed-price with an ultimate completion date of August 27, 2025, and carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA under the SPE2DB program, a $499.9 million single-award vehicle that enables the agency to procure a comprehensive range of pharmaceutical products to support medical supply needs across Department of Defense healthcare facilities worldwide.
Trogarzo is a prescription medication used in HIV treatment regimens, and this delivery order reflects DLA's ongoing pharmaceutical procurement operations to maintain inventory for military health systems. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, leveraging its woman-owned small business status to compete effectively for contracts covering branded and generic prescription drugs, biologics, and medical consumables. The company's extensive contract history with DLA demonstrates its capability to reliably deliver specialized pharmaceutical products to defense healthcare infrastructure globally.
Quick answers
Who was awarded contract SPE2DB25FPRB1?
SPE2DB25FPRB1 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 6, 2025.
How much is contract SPE2DB25FPRB1 worth?
The government has obligated $46,650 on SPE2DB25FPRB1.
Is contract SPE2DB25FPRB1 an order under another contract?
Yes. SPE2DB25FPRB1 is a delivery order under SPE2DB20D9127, an indefinite delivery contract.
Was contract SPE2DB25FPRB1 competed?
The extent of competition for SPE2DB25FPRB1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award